The US Chamber of Commerce has criticised India’s “recent pattern of pharma patent denials”, which it says “are not about access to medicine”.
If you have already subscribed please login.
If you have any technical issues please email tech support.
US Chamber of Commerce, Indian Patent Office, Glivec, Priority Foreign Country
